InsidersTradesSigma
Follow the 訊聯基因 share price and the full directors' dealings record of the company, a publicly traded company based in Taiwan. Shares trade on the TW market, under the supervision of TWSE / TPEx (MOPS). Market capitalisation: €1.1bn. The latest transaction was disclosed on 13 May 2026 (Negotiated). Among the most active insiders: 蔡政憲. Every trade is free.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
訊聯基因 is a company listed on the XTAI market, specializing in genomics and biotechnology. It focuses on developing innovative solutions for health and personalized medicine.